Joaquim Moita

Joaquim Moita

Auto-generated profile, based on publicly available information

Joaquim Moita

General Hospital, Coimbra University Hospital Center, Portugal

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
LGLaetitia Gaspar
Laetitia Gaspar
AÁAna Rita Álvaro
Ana Rita Álvaro
JMJoaquim Moita
Joaquim Moita
CCCláudia Cavadas
Cláudia Cavadas

1 January 2001 in Chest
Verified
Journal Article
Closed access
PPPatrick Petitpretz
Patrick Petitpretz
PAPierre Arvis
Pierre Arvis
MMMiroslav Marel
Miroslav Marel
JMJoaquim Moita
Joaquim Moita
JUJuan Urueta
Juan Urueta

30 September 2019 in Pulmonology
Verified
Journal Article
Open access
JCJ. Coutinho Costa
J. Coutinho Costa
Alexandre Rebelo-MarquesAlexandre Rebelo-Marques
Alexandre Rebelo-Marques
JMJ.N. Machado
J.N. Machado
JGJorge Gama
Jorge Gama
CSC. Santos
C. Santos
JMJ. Moita
J. Moita
Screening methods have become increasingly important due to the growing number of patients suspected of having obstructive sleep apnea (OSA) being referred to sleep clinics. The Lausanne NoSAS (Neck circumference, Obesity, Snoring, Age, Sex) score test is a simple, efficient, and easily employed tool enabling identification of individuals at risk for the disease. The score ranges from 0 to 17 and the patient has a high probability of OSA if they have a NoSAS score of 8 or higher. To evaluate the performance of the NoSAS score as a screening tool for the diagnosis of OSA in a sleep clinic. Prospectively, for 12 months, we included all the patients referred by primary care physicians to our sleep unit for clinical evaluation who had undergone in-lab polysomnography (PSG) and completed the NoSAS score. This test assigns 4 points for a neck circumference of more than 40cm, 3 points for a body-mass index of 25kg/m2 to less than 30kg/m2 or 5 points for having a body-mass index of 30kg/m2 or more, 2 points for snoring, 4 points for being older than 55 years of age and 2 points for being male. Of the 294 patients, 70.7% were male, aged 53.5±12.1 years, with a neck circumference of 41.0±3.6cm and a BMI of 30.8±5.1kg/m2. OSA was present in 84.0% of the patients, 34.8% with moderate OSA and 36.4% severe OSA. Using the NoSAS model for the prediction of all OSA, moderate/severe OSA and severe OSA, the area under the ROC (Receiver Operating Characteristic) was 0.770 (IC95%: (0.703; 0.837), p<0.001), 0.746 (IC95%: (0.691; 0.802), p<0.001) and 0.686 (IC95%: (0.622; 0.749), p<0.001), respectively, thus confirming the diagnostic ability of the NoSAS model. With a NoSAS score ≥7, the sensitivity and positive predictive value (PPV) were 94.3% and 87.6% for all OSA, 94.9% and 62.8% for moderate/severe OSA and 100% and 33.8% for severe OSA, respectively. With the same cut-off, the negative predictive value (NPV) for moderate/severe and severe OSA were 67.9% and 100%, respectively. Each increase in the NoSAS score was associated with an increase in the probability of OSA, reaching a 97% OSA probability for a score of 17. The NoSAS score showed high sensitivity and PPV for OSA with specificity and diagnostic accuracy steadily increasing with higher scores. Furthermore, a low score showed high predictive value for the exclusion of moderate/severe OSA. Overall, our results suggest that, in primary care, this score can be a powerful tool for stratifying and prioritizing patients in the diagnosis of OSA. Nevertheless, more studies are needed to evaluate the efficacy of this score in hospital health care, in younger populations, with a predominance of female and non-obese individuals or in cardiovascular disease.

1 February 2008 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JMJ. Moita
J. Moita
CBCristina Barbara
Cristina Barbara
JCJ. Cardoso
J. Cardoso
RCR. Costa
R. Costa
MSM. Sousa
M. Sousa
MSM.L. Santos
M.L. Santos

30 July 2018 in Pulmonology
Verified
Journal Article
Open access
IGI. Gonçalves
I. Gonçalves
MGM.J. Guimarães
M.J. Guimarães
MZM. van Zeller
M. van Zeller
FMF. Menezes
F. Menezes
JMJ. Moita
J. Moita
OCOn Behalf Of The Gi Dpoc-Grupo de Interesse na Doença Pulmonar Obstrutiva Crónica
On Behalf Of The Gi Dpoc-Grupo de Interesse na Doença Pulmonar Obstrutiva Crónica
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, and there is a clinical need for validated markers and biomarkers that can contribute to the assessment of patients, risk prediction, treatment guidance, and assessment of response. Although according to the 2018 GOLD guidelines clinically useful biomarkers for COPD patients in stable condition have yet to be identified, several clinical markers and biomarkers have been proposed for COPD. These include isolated clinical markers, such as symptoms and Health Status assessment, exercise tests, function tests and imaging, and also composite scores and molecular markers. However, and despite strong efforts to identify useful markers in an attempt to improve prognostic and therapeutic approaches, results have not been consistent and expectations of relying on these markers in near future are faint. Current approaches to COPD have shifted from treating the disease to treating the individual patient. There is a clear need to identify treatable traits, focusing more on the patient and not on the disease, in order to implement an increasingly personalized treatment of COPD in the clinic, leading to true precision medicine. There is a need to identify combinations of clinical markers and biomarkers, genetic markers, and phenotypes that can guide the personalized therapy of COPD patients. This critical review will therefore focus not only on currently established markers and biomarkers in COPD but also on possible future approaches toward precision medicine.

29 December 2017 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
Alexandre Rebelo-MarquesAlexandre Rebelo-Marques
Alexandre Rebelo-Marques
CVCláudia Vicente
Cláudia Vicente
BVBruno Valentim
Bruno Valentim
MAMarcos Agostinho
Marcos Agostinho
RPRosália Pereira
Rosália Pereira
JMJoaquim Moita
Joaquim Moita